WO2001030308A1 - Dual chamber cleansing system comprising multiple emulsion - Google Patents

Dual chamber cleansing system comprising multiple emulsion Download PDF

Info

Publication number
WO2001030308A1
WO2001030308A1 PCT/EP2000/009762 EP0009762W WO0130308A1 WO 2001030308 A1 WO2001030308 A1 WO 2001030308A1 EP 0009762 W EP0009762 W EP 0009762W WO 0130308 A1 WO0130308 A1 WO 0130308A1
Authority
WO
WIPO (PCT)
Prior art keywords
surfactant
water
oil
stripe
emulsion
Prior art date
Application number
PCT/EP2000/009762
Other languages
French (fr)
Inventor
Dale St Lewis
Helen Elizabeth Knaggs
Mark Stephen Naser
Philippe Cham
Original Assignee
Unilever Plc
Unilever Nv
Hindustan Lever Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc, Unilever Nv, Hindustan Lever Limited filed Critical Unilever Plc
Priority to CA002385718A priority Critical patent/CA2385718A1/en
Priority to AU10217/01A priority patent/AU1021701A/en
Priority to JP2001532728A priority patent/JP2003512408A/en
Publication of WO2001030308A1 publication Critical patent/WO2001030308A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • A61K8/0233Distinct layers, e.g. core/shell sticks
    • A61K8/0237Striped compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/066Multiple emulsions, e.g. water-in-oil-in-water
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88Two- or multipart kits

Definitions

  • the present invention relates to a composition for depositing water soluble benefit agents (e.g., glycolic acid, lactic acid, hydroxy caprylic acid, water soluble vitamins etc. ) in greater amounts than previously possible when using personal wash shower gel type liquids and/or facial cleansers while maintaining good foam stability.
  • water soluble benefit agents e.g., glycolic acid, lactic acid, hydroxy caprylic acid, water soluble vitamins etc.
  • the invention relates to a dual chamber system in which one composition/stripe comprises a surfactant; and a separate composition/stripe, which is co-dispensed, comprises a multiple emulsion which in turn comprises a benefit agent emulsion (e.g., water soluble glycolic acid in oil) emulsified in a water solution containing additional water soluble benefit agent (e.g., glycerol, PEGs, PPG, etc. )
  • a benefit agent emulsion e.g., water soluble glycolic acid in oil
  • additional water soluble benefit agent e.g., glycerol, PEGs, PPG, etc.
  • water soluble benefit agents e.g., glycolic acid; lactic acid
  • water soluble benefit agent is extremely difficult to accomplish, particularly from wash- off type products (e.g., shower gels) because the water soluble benefit agent will essentially wash off when the user rinses with water.
  • wash- off type products e.g., shower gels
  • hydrophobic benefit agent e.g., silicone or petrolatum
  • the applicants have found that, by forming a multiple emulsion of a water soluble benefit agent and separately dispensing the water soluble benefit agent containing multiple emulsion in one stripe and a surfactant containing composition in another, the applicants have been able to deposit greater amounts of water soluble benefit agent than otherwise achievable (e.g., either through a single stripe cleanser, or through dual stripe cleanser having only oil in water emulsion, rather than the water-in- oil-in-water emulsion of invention) .
  • a dual chamber dispenser comprising a surfactant containing stripe on one side and a multiple emulsion containing stripe on the other (wherein the emulsion is a water in oil in water emulsion, and wherein the internal water phase contains at least one water soluble benefit agent) is able to deliver water soluble benefit agent to the skin or other substrate in greater amounts than otherwise possible, i.e., using single stripe, or using different type of emulsion in the two stripe system such as oil in water only.
  • the invention comprises:
  • an aqueous liquid cleansing and moisturising composition comprising an at least dual chamber dispenser (in theory more than two stripes may be dispensed, and the invention is not necessarily limited by the number of stripes) comprising: (A) 10 to 99.9% by wt . , preferably 30 to
  • a surfactant containing stripe wherein about 1 to 75%, preferably 5 to 70% of said surfactant stripe comprises a surfactant selected from the group consisting of anionic, nonionic, zwitterionic and cationic surfactants, soap and mixtures thereof (water, solute, opacifier, bactericides and other standard ingredients may also be found in the stripe) ; and
  • (B) 0.1 to 90%, preferably 0.1 to 70%, more preferably 0.1 to 50% by wt . of a multiple emulsion stripe comprising: (1) 1 to 99%, preferably 2 to 90% of said multiple emulsion of a water in oil (W ⁇ /0) emulsion comprising:
  • a 0 to 30%, preferably 0.01 to 5% of a high (10-30) HLB nonionic surfactant (e.g., Brij 58) which may be used to stop oil in the oil phase from leaking out of the W 2 phase to form separate oil layer;
  • a high (10-30) HLB nonionic surfactant e.g., Brij 58
  • Brij 58 a high (10-30) HLB nonionic surfactant
  • second topically active compound e.g., glycerin
  • the 2 phase could be nothing but water.
  • a nonionic gum polymer is preferably present in W2 and, if W2 is predominantly amphoteric (>50%) , an anionic gum polymer is preferably present.
  • the present invention relates to an at least dual chamber dispenser comprising a surfactant containing stripe on one side ( (A) above) and a multiple emulsion containing stripe ((B) above) on the other.
  • the multiple emulsion is a water in oil in water emulsion (W1-O-W2) wherein the internal water phase contains a water soluble benefit agent (e.g., glycolic acid) .
  • W1-O-W2 water in oil in water emulsion
  • a water soluble benefit agent e.g., glycolic acid
  • One stripe of the dispenser of the invention is the surfactant stripe (Component A) .
  • the surfactant containing stripe is really not limited in any way and any viable surfactant system may be used, although preferably this will be a "mild" surfactant system.
  • the surface active agent can be selected from any known surfactant suitable for topical application to the human body. As noted, mild surfactants, i.e., surfactants which do not damage the stratum corneum, the outer layer of skin, are particularly preferred.
  • fatty acyl isethionate of formula :
  • R is an alkyl or alkenyl group of 7 to 21 carbon atoms and M is a solubilizing cation such as sodium, potassium, ammonium or substituted ammonium.
  • M is a solubilizing cation such as sodium, potassium, ammonium or substituted ammonium.
  • RCO groups Preferably at least three quarters of the RCO groups have 12 to 18 carbon atoms and may be derived from coconut, palm or a coconut/palm blend.
  • alkyl ether sulphate of formula:
  • R is an alkyl group of 8 to 22 carbon atoms
  • n ranges from 0.5 to 10 especially from 1.5 to 8
  • M is a solubilizing cation as before.
  • anionic surfactants include alkyl glyceryl ether sulphate, sulphosuccinates, taurates, sarcosinates, sulphoacetates, alkyl phosphate, alkyl phosphate esters and acyl lactylate, alkyl glutamates and mixtures thereof.
  • Sulphosuccinates may be monoalkyl sulphosuccinates having the formula:
  • R ranges for C 8 -C 2 0 alkyl, preferably C 12 -C 15 alkyl and M is a solubilizing cation.
  • R ranges from C8-C20 alkyl, preferably C12-C 1 5 alkyl and M is a solubilizing cation.
  • Taurates are generally identified by the formula:
  • R ranges from C 8 -C2 0 alkyl preferably C 1 2-C 15 alkyl
  • R ranges from C 1 -C alkyl
  • M is a solubilizing cation. Harsh surfactants such as primary alkane sulphonate or alkyl benzene sulphonate will generally be avoided.
  • Suitable nonionic surfactants include alkyl polysaccharides, lactobionamides , ethylene glycol esters, glycerol monoethers, polyhydroxyamides (glucamide) , primary and secondary alcohol ethoxylates, especially the C 8 -C20 aliphatic alcohols ethoxylated with an average of from 1 to 20 moles of ethylene oxide per mole of alcohol.
  • the soap is preferably derived from materials with a Cs to C2 2 substantially saturated carbon chain and, preferably, is a potassium soap with a C 1 2 to C ⁇ 8 carbon chain.
  • the surfactant is preferably present at a level of from 1 to 75 wt.%, preferably 5 to 70 wt . % .
  • the composition includes from 0.5 to 15 wt.% of a co-surfactant agent with skin mildness benefits.
  • Suitable materials are zwitterionic surfactants which have an alkyl or alkenyl group of 7 to 18 carbon atoms and comply with an overall structural formula:
  • R is alkyl or alkenyl of 7 to 18 carbon atoms
  • R are each independently alkyl, hydroxyalkyl or carboxyalkyl of 1 to 3 carbon atoms; m is 2 to 4; n is 0 or 1;
  • X is alkylene of 1 to 3 carbon atoms optionally substituted with hydroxyl
  • Y is -CO2 or -S0 3 .
  • Zwitterionic surfactants within the above general formula include simple betaines of formula:
  • R may, in particular, be a mixture of C 1 2 and C1- 3 alkyl groups derived from coconut so that at least half, preferably at least three quarters, of the group R has 10 to 14 carbon
  • R and R are preferably methyl.
  • a further possibility is a sulphobetaine of formula:
  • a structurant may be added to the phase comprising the surfactant.
  • Suitable materials include swelling clays, for example laponite; fatty acids and derivatives thereof, in particular, fatty acid monoglyceride polyglycol ethers; cross-linked polyacrylates such as CarbopolTM (polymers available from Goodrich) ; acrylates and copolymers thereof; polyvinylpyrrolidone and copolymers thereof; polyethylene imines; salts such as sodium chloride and ammonium sulphate; sucrose esters; gellants; and mixtures thereof.
  • swelling clays for example laponite
  • fatty acids and derivatives thereof in particular, fatty acid monoglyceride polyglycol ethers
  • cross-linked polyacrylates such as CarbopolTM (polymers available from Goodrich)
  • acrylates and copolymers thereof polyvinylpyrrolidone and copolymers thereof
  • polyethylene imines salts such as sodium chloride and ammonium sulphate
  • Suitable electrolytes include alkali and alkaline earth salts such as halides, ammonium salts and sulphates.
  • the surfactant phase may also comprise a thickening agent, i.e., a material which maintains the viscosity of this phase as the shear rate thereof is increased during use.
  • a thickening agent i.e., a material which maintains the viscosity of this phase as the shear rate thereof is increased during use.
  • Suitable materials include cross-linked polyacrylates such as
  • CarbopolTM polymers available from Goodrich) ; natural gums including alginates, guar, xanthan and polysaccharide derivatives including carboxy methyl cellulose and hydroxypropyl guar; propylene glycols and propylene glycol oleates; salts such as sodium chloride and ammonium sulfate; glycerol tallowates; and mixtures thereof. It should be appreciated that, although there is a separate benefit agent stripe (i.e., the multiple emulsion stripe
  • some benefit agent e.g., hydrophobic agents such as silicone, petrolatum; or hydrophilic benefit agents or water soluble agents such as polyglycerin
  • Other components which may be used in the surfactant stripe are soluble/salts (e.g., alkali metal chloride), for example, to control viscosity; small amounts of opacifiers (preferably 0.2 to 2%), preservatives (0.2 to 2.0 wt. %) , perfumes (0.5 to 2.0 wt.%) etc.
  • the separate benefit agent stripe is a multiple emulsion stripe which is similar to the stable emulsion described in " Phase Stable Multiple Emulsion Compositions" to Naser et al., filed on same date as subject application and hereby incorporated by reference into the subject application.
  • the multiple emulsion composition comprises both a water in oil portion and an external water emulsion surrounding the water in oil emulsion. More specifically, the multiple emulsion comprises:
  • a W ⁇ /0 emulsion which itself comprises (a) about 1 to 99% internal aqueous phase containing water, 0.01 to 30% optional solute and 0 to 30% optional surfactant; (b) 0.5 to 99% oil phase O surrounding said internal aqueous phase comprising a non- volatile silicone compound, a volatile hydrocarbon compound, a non-volatile hydrocarbon compound or mixtures thereof;
  • the water phase of the ⁇ /0 part of emulsion will generally comprise droplets with an internal aqueous phase containing water, optional solute (preferably 0.01 to 30%) and a topically active compound (e.g., glycolic and/or lactic acid) ; and an oil phase surrounding said internal aqueous phase.
  • Droplets may range from 0.1 to about 10 microns and may be enveloped by a membrane or film comprising oil and low HLB emulsifier.
  • the WiO emulsion is present in an amount 1-99%, preferably 2 to 90%, more preferably 5 to 90%, most preferably 10 to 70% by wt . of multiple emulsion 1-O- 2.
  • i aqueous phase comprise 1 to 99% by wt . of the emulsion with small amounts of oil and low HLB emulsifier separating Wi and W 2 .
  • the water phase may comprise water, solute and water-soluble topically active compound (oil soluble active may also be in oil phase) . It may also comprise additional active compounds and/or optional water soluble compounds providing desired aesthetic or functional effect (e.g., perfume).
  • the Wi phase may comprise 1-99%, preferably 10-95% of Wi/O emulsion, more preferably 25 to 95% of emulsion.
  • the topically active compound may enter the water or oil phase depending on solubility (e.g., water soluble compound in water phase and oil soluble in oil phase) .
  • water soluble means water soluble or water dispersible.
  • a water soluble compound has a water solubility of at least 0.1 g (grams) per 100 ml (milliliters) of water and forms a true solution.
  • a water soluble compound can be inherently water soluble or can be made water soluble by the addition of a solubilizing compound, such as a coupling agent, a co-surfactant, or a solvent.
  • a solubilizing compound such as a coupling agent, a co-surfactant, or a solvent.
  • a water dispersible compound remains dispersed in water for at least the time period necessary to manufacture the primary W /0 emulsion, i.e., at least about one hour.
  • the topically active compound can be incorporated into the external aqueous phase W 2 to achieve enhanced efficacy.
  • the topically active compound therefore can be one of, or a combination of, a cosmetic compound, a medicinally active compound or any other compound that is useful upon topical application to the skin or hair.
  • Such topically active compounds include, but are not limited to, hair conditioners (e.g., water soluble quaternary ammonium compounds, alkoxylated and nonalkoxylated fatty amines, dimethicone copolyols, cationic polymers etc.), skin conditioners (e.g., humectants such as glucose, glycerin, propylene glycol, amino acids, vitamins, amino functional silicones, etc.), hair and skin cleansers, hair fixatives, hair dyes, hair growth promoters, deodorants (e.g., organic and inorganic salts of aluminum, zirconium, zinc and mixtures thereof) , skin care compounds, permanent wave compounds, hair relaxers, hair straighteners, antibacterial compounds, antifungal compounds, anti-inflammatory compounds, topical anesthetic
  • Sufficient water is present in the aqueous phase such that the aqueous phase comprises about 1% to about 95% by weight of the primary emulsion.
  • Total water present in the 1 -O- 2 multiple emulsion composition is about 30% to about 99.9%, and typically about 40% to about 95%, by weight of the composition.
  • solutes include solutes.
  • solutes which may be added are salts such as alkali metal chloride. Solute added to the internal aqueous phase may comprise 0 to 30% by wt., preferably 0.1-10% by wt .
  • the surfactant can be any of the surfactants discussed in connection with the 2 phase below.
  • the internal aqueous phase also can include optional ingredients traditionally included in topically applied compositions. These optional ingredients include, but are not limited to, dyes, fragrances, preservatives, antioxidants, detackifying agents, and similar types of compounds.
  • the internal phase may also include polyalkylene oxide components. These may be particularly useful for incorporating certain hydrophilic benefit agents (e.g., salicylic acid) which may otherwise be difficult to add to the internal aqueous phase.
  • the optional ingredients are included in the internal aqueous phase of the primary emulsion in an amount sufficient to perform their intended function.
  • the oil phase may be volatile (except for silicone) or nonvolatile .
  • a volatile oil may comprise a volatile hydrocarbon oil which evaporates during the process of drying skin or hair, and thereby releases the internal aqueous Wi phase, which includes the first topically active compound to contact the skin or hair.
  • This oil preferably should contain no volatile silicone since volatile silicones tend to destabilize the multiple emulsion.
  • the oil may comprise a combination of a volatile oil (except for silicone) and a .nonvolatile oil.
  • an oil can be designed to evaporate at a pre-selected temperature and provide a controlled release of the first topically active compound at the pre-selected temperature.
  • Pre-selected temperatures are those encountered during normal hair drying, provided by a hair dryer, or provided by a curling iron.
  • the oil also can include a water insoluble topically active compound in a sufficient amount to impart a particular functional or aesthetic effect (e.g., emolliency) , as long as the topically active compound does not adversely affect the W 1 -O-W 2 multiple emulsion composition (e.g., does not impart emulsion instability).
  • a particular functional or aesthetic effect e.g., emolliency
  • the topically active compound does not adversely affect the W 1 -O-W 2 multiple emulsion composition (e.g., does not impart emulsion instability).
  • Volatile hydrocarbon compounds incorporated into the primary emulsion include, for example, isododecane and isohexadecane, i.e., PERMETHYL 99A, PERMETHYL 101A and PERMETHYL 102A, available from Presperse, Inc., South Plainfield, N.J.
  • Other exemplary volatile hydrocarbon compounds are depicted in general structural formula (I), wherein n ranges from 2 to 5.
  • Another exemplary volatile hydrocarbon compound is ISOPAR M
  • the volatile hydrocarbon is less than 50% unsaturated.
  • the oil also can be a non-volatile oil.
  • the non-volatile oil comprises a non-volatile silicone compound, a non-volatile hydrocarbon, or a mixture thereof.
  • the non-volatile oil comprises compounds which contain less than 50% unsaturation.
  • the non-volatile oil does not evaporate from the skin or hair. The first topically active compound therefore is released by rubbing the skin or hair to rupture the primary W ⁇ /0 emulsion.
  • a non-volatile oil phase has a boiling point at atmospheric pressure of greater than about 250°C.
  • non-volatile silicone compounds include a polyalkyl siloxane, a polyaryl siloxane or a polyalkylaryl siloxane. Mix of these non-volatile silicone compounds also are useful.
  • the non-volatile oil also can comprise a non-volatile hydrocarbon compound, such as mineral oil, petrolatum, sunflower seed oil, canola oil or miters thereof.
  • a non-volatile hydrocarbon compound such as mineral oil, petrolatum, sunflower seed oil, canola oil or miters thereof.
  • Other exemplary non-volatile hydrocarbon compounds that can be incorporated into the oil phase include, but are not limited to, a branched 1-decene oligomer, like 1-decene dimer or a polydecene.
  • the oil also optionally can comprise (1) an oil, such as jojoba oil, wheat germ oil or purcellin oil; or (2) a water insoluble emollient, such as, for example, an ester having at least about 10 carbon atoms, and preferably about 10 to about 32 carbon atoms.
  • an oil such as jojoba oil, wheat germ oil or purcellin oil
  • a water insoluble emollient such as, for example, an ester having at least about 10 carbon atoms, and preferably about 10 to about 32 carbon atoms.
  • Suitable esters include those comprising an aliphatic alcohol having about eight to about twenty carbon atoms and an aliphatic or aromatic carboxylic acid including from two to about twelve carbon atoms, or conversely, an aliphatic alcohol having two to about twelve carbon atoms with an aliphatic or aromatic carboxylic acid including about eight to about twenty carbon atoms.
  • the ester is either straight chained or branched.
  • the ester has a molecular wt . of less than about 500.
  • Suitable esters therefore include, for example, but are not limited to:
  • aliphatic monohydric alcohol esters e.g., isopropyl isostearate, cetyl acetate, cetyl stearate
  • myristyl propionate isopropyl myristate, isopropyl palmitate, cetyl acetate, cetyl propionate, cetyl stearate
  • aliphatic polyhydric alcohol esters e.g., propylene glycol dipelargonate
  • aliphatic esters of aromatic acids e.g., C12-C15 alcohol esters of benzoic acid
  • the oil phase of the present invention also may include about 0.1% to about 30%, and preferably about 0.1% to about 15%, on the weight of the oil of a low HLB emulsifier.
  • the low HLB emulsifier may comprise a silicon-free surfactant, or a blend of silicon-free surfactants, having an HLB value of about 10 or less (i.e., an HLB value of about 0.1 to about 10), an oil-soluble silicon-based surfactant, an oil-soluble polymeric surfactant, or mixtures thereof.
  • the silicon-free surfactant or surfactant blend has an HLB value of about 1 to about 7.
  • the silicon-free surfactant or surfactant blend has an HLB value of about 3 to about 6.
  • oil-soluble as used herein means a compound having a solubility of at least 0.1 g per 100 ml of oil phase to form a true solution.
  • the HLB value of a particular silicon-free surfactant can be found in McCutcheon ' s Emulsifiers and Detergen ts , North
  • the HLB value of a particular surfactant can be estimated by dividing the weight percent of oxyethylene in the surfactant by five (for surfactants including only ethoxy moieties).
  • the HLB value of a surfactant blend can be estimated by the following formula:
  • HLB (wt.% A) (HLB A ) + (wt.% B) (HLB B ) ,
  • wt . % A and wt . % B are the weight percent of surfactants A and B in the silicon-free surfactant blend
  • HLB A and HLB B are the HLB values for surfactants A and B, respectively.
  • Low HLB surfactant can be a silicone-based surfactant or silicone-free surfactant.
  • silicon-free nonionic surfactants include, but are not limited to, polyoxyethylene ethers of fatty (Cg-C22) alcohols, polyoxyethylene/polyoxypropylene ethers of fatty (C6-C22) alcohols, ethoxylated alkylphenols, polyethylene glycol ethers of methyl glucose, polyethylene glycol ethers of sorbitol, and mixtures thereof.
  • Exemplary silicon-free nonionic surfactants are the ethoxylated alcohols having an HLB value of about 0.1 to about 10.
  • An especially preferred ethoxylated alcohol is laureth-1, i.e., lauryl alcohol ethoxylated with an average of one mole of ethylene oxide.
  • Other suitable ethoxylated alcohols include laureth-2, laureth-3 and laureth-4.
  • Numerous other nonionic surfactants having an HLB of about 0.1 to about 10 are listed in McCutcheon' s at pages 229-236, incorporated herein by reference.
  • exemplary silicon- free nonionic surfactants having an HLB value of about 0.1 to about 10 include, but are not limited to, the ethoxylated nonylphenols, ethoxylated octylphenols, ethoxylated dodecylphenols, ethoxylated fatty (C6-C22) alcohols having four or fewer ethylene oxide moieties, oleth-2, steareth-3, steareth-2, ceteth-2, oleth-3,and mixtures thereof.
  • the emulsifier can also comprise a silicon-free surfactant blend having an HLB value of about 1 to about 10.
  • the blend is a mixture of a sufficient amount of a surfactant having allow HLB value, i.e., about 0.1 to about 10, and a sufficient amount of a surfactant having a higher HLB value, i.e., about 1 to greater than about 10, such that the surfactant blend has an HLB value of about 1 to about 10.
  • Exemplary, but non-limiting, nonionic surfactants having a high HLB value are listed in McCutcheon ' s at pages 236-246, incorporated herein by reference.
  • a preferred silicone-free surfactant is PEG-30 dipolyhydroxystearate .
  • An exemplary oil-soluble silicon-based surfactant is a dimethicone copolyol, which is a dimethylsiloxane polymer having polyoxyethylene and/or polyoxypropylene side chains, such as DOW CORNING 322C FORMULATION AID, available from Dow Corning Co., Midland, Mich.
  • the dimethicone copolyol has about 15 or fewer ethylene oxide and/or propylene oxide monomer units, in total, in the side chains.
  • Dimethicone copolyols conventionally are used in conjunction with silicones because the silicon-containing surfactants are extremely soluble in a volatile or a non-volatile silicone compound, are extremely insoluble in water, and have a low skin irritancy potential.
  • alkyl dimethicone copolyol such as cetyl dimethicone copolyol available commercially as ABIL (R) EM 90 from Goldschmidt Chemical Corporation, Hopewell, Va .
  • the alkyl dimethicone copolyols have the structure:
  • p is a numeral from 7 through 17; q is a numeral from 1 through 100; m is a numeral from 1 through 40; n is a numeral from 0 through 200; and PE is (C 2 H 4 O) a (C3H 6 O) _ H having a molecular weight of about 250 to about 2000, wherein a and b are selected such that the weight ratio of C 2 H 4 ⁇ /C 3 H 6 0 is from 100/0 to20/80.
  • the emulsifier may also be an oil-soluble polymeric surfactant.
  • Polymeric surfactants capable of forming water- in-oil emulsions completely cover the surface of the water droplet, are firmly anchored at the oil-water interface, the external oil phase is a good solvent for the stabilizing portion of the polymeric surfactant, and the thickness of the polymer layer on the oil side of the interface is sufficient to ensure stability.
  • These surfactants may include ethoxy, propoxy and/or similar alkylene oxide monomer units, e.g., butoxy.
  • the oil-soluble polymeric surfactants act as surfactants and are not physically or chemically cross-linked in solution.
  • the oil-soluble polymeric surfactants therefore are differentiated from polymeric gelling agents such as polyacrylic acid or polymethacrylic acid.
  • oil-soluble polymeric surfactants include, but are not limited to, polyoxyethylene- polyoxypropylene block copolymers, and similar polyoxyalkylene block copolymers.
  • the oil-soluble block copolymers typically have less than about 20% by weight of ethylene oxide.
  • oil-soluble polymeric surfactants include Poloxamer 101 , Poloxamer 105, PPG-2- Buteth-3, PPG-3-Butech-5, PPG-5-Butech-7 , PPG-7-Butech-10, PPG-9-Buteth-12, PPG-12-Buteth-16, PPG-15-Buteth-20, PPG-20- Buteth-30, PPG-24-Buteth-27, PPG-28-Buteth-35, and PEG-15 Butanediol.
  • Other useful oil-soluble polymeric surfactants are polyamines, i.e., polyoxyethylene-polyoxypropylene block copolymers of ethylene diamine, having less than about 40% by weight ethylene oxide.
  • the hydrophobic moiety of a silicon-free surfactant, silicon-containing surfactant or polymeric surfactant is sufficiently soluble in the oil phase such that a sufficient amount of the surfactant is present in the oil phase to stabilize the primary W ⁇ /0 emulsion.
  • the surfactant phase comprises either a silicon- based surfactant, a silicon-free surfactant having a hydrophobic moiety preferably containing about ten to about fourteen carbon atoms, an oil-soluble polymeric surfactant, or a mixture thereof. If the hydrophobic moiety of the silicon-free surfactant is saturated and includes more than about 14 carbon atoms, the silicon-free surfactant is insoluble in the silicone phase and the primary ⁇ /0 emulsion is unstable. If the hydrophobic moiety includes less than about 10 carbon atoms, the primary W ⁇ /0 emulsion has a tendency to coalesces i.e., the emulsion droplets fuse to form large droplets.
  • the amount of surfactant phase necessary to provide a primary emulsion of desired W /0 droplet diameter varies with the amount of aqueous phase in the primary emulsion and is easily determined by those skilled in the art.
  • One particularly preferred emulsifier is cetyl dimethicone copolyol.
  • the external aqueous phase ( 2) of the W 1 -O- 2 multiple emulsion may comprise an isotropic mixture of surfactants phase (as opposed to lamellar phase of U.S. Patent No. 5,656,280), if surfactants are present.
  • the phase may also comprise 0-60% by wt . of phase, preferably 10-50% of a second topically active compound, similar to or different from the first topically active compound and optional solute and optional (preferably 0.01 to 10%) of a stabilizing natural gum polymer.
  • surfactant may be a non- amido anionic or all amphoteric or mixtures of the two.
  • Surfactant may be absent, but will typically comprise 2-80% of aqueous phase.
  • This external phase may comprise a mixture of anionic and/or nonionic (or other) surfactants in combination with amphoteric surfactants wherein anionic/nonionic comprises 1 to 99% of the surfactant system and amphoteric comprises 1 to 99% of the surfactant system, i.e., one should not ideally be present to the exclusion of the other.
  • surfactant can be any of the surfactants described in connection with the surfactant stripe phase. More specifically, if surfactant is entire or majority (>60%) anionic, it is preferred nonionic gum polymer be used.
  • guar gum which is structurally composed of a straight chain of D-mannose with a D-galactose side chain on approximately every other mannose unit.
  • the usual ratio of mannose to galactose is approximately 2:1 and molecular weights are usually on the order of 100,000 to 1,000,000.
  • locust bean gum a galactomannan consisting of a main chain of D-mannose units with single galactose side chains on approximately every fourth unit.
  • approximate molecular weights are between 100,000 and 1,000,000.
  • an anionic gum polymer is preferred. These can be seaweed polysaccharides, exudate polysaccharides, or microbial polysaccharides.
  • a preferred anionic seaweed polysaccharide is carrageenan, or "Irish moss," a complex mixture of sulfated polysaccharides.
  • Carrageenan is a mixture of galactans that carry varying proportions of half-ester sulfate groups linked to one or more of the hydroxyl groups of the galactose units, which are joined by alternating ⁇ -1,3 and ⁇ -1,4 glycosidic linkages.
  • the molecular weight usually ranges from 100,000 to 1,000,000.
  • a preferred anionic exudate polysaccharide is gum tragacanth, a complex mixture of acidic polysaccharides containing galacturonic acid, galactose, fucose, xylose, and arabinose.
  • Another preferred anionic exudate polysaccharide is gum karaya, a partially acetylated high molecular weight polysaccharide which contains L-rhamnose, D-galactose, D- galacturonic acid, and D-glucuronic acid residues.
  • amphoteric surfactants or amphoteric rich surfactant systems are microbial anionic hetero- polysaccharide gums, most preferably xanthan gum.
  • the primary structure of these microbial gums contains two glucose units, two mannose units, and one glucuronic acid unit .
  • the benefit agent stripe (with multiple emulsion) and surfactant stripe are separate but combinedly dispensable from a packaging means and typically a single packaging means.
  • a packaging means includes those systems which comprise two separate compartments. Ensuring that the surfactant and benefit agent are separate can be achieved in a variety of ways. Packaging of the composition such that the surfactant and benefit agent are presented in separate compartments or in separate domains within the packaging; including encapsulation of the benefit agent; and by processing of the composition by co-extrusion to produce a striped product in which individual stripes contain either the surface active agent or benefit agent.
  • compositions of the invention may be formulated as products for washing the skin, for example, bath or shear gels, hand washing compositions or facial washing liquids; pre- and post-shaving products; rinse-off, wipe-off and leave-on skin care products; products for washing the hair and for dental use.
  • compositions of the invention will generally be pourable liquids or semi-liquids, e.g., pastes and will have a viscosity in the range of 250 to 100,000 mPas measured at a shear rate 10s and 25°C in a Haake rotoviscometer RV20.
  • the viscosity will generally be in the range 200 to 15000 mPas, preferably
  • the viscosity will generally be in the range 3000 to 100,000 mPas measured at a shear rate 10s and 25°C.
  • compositions include opacifiers, preferably 0.2 to 2.0 wt.%; preservatives, preferably 0.2 to 2.0 wt.% and perfumes, preferably 0.5 to 2.0 wt.%.
  • Fresh Piglet skin (4-5 weeks old, male, white, no nipples and shaved) is used for the deposition studies.
  • the skin is cut into -12 cm x 5 cm pieces which are stretched and pinned onto a support.
  • the surface of the skin is wetted with 250 ml water and 1 gram of cleanser is applied to the wet surface (0.5 gram benefit stripe and 0.5 gram of surfactant phase) .
  • the skin is then washed by hand for 30-60 seconds, rinsed three times with 250 ml aliquots of water and patted dry with Kimwipe paper towel.
  • a glass/plastic cylinder 3.3 cm in diameter is then placed in close contact with the skin surface and the skin is extracted three times with 3 ml aliquots of organic solvent (ethanol, acetone or tetrahydrofuran) followed by another three times with 3 ml aliquots of distilled water.
  • organic solvent ethanol, acetone or tetrahydrofuran
  • the organic solvent extracts are combined. The same is done for the water extracts.
  • the water and/or organic solvent extractions can be repeated several times depending on the concentration of sodium glycolate or glycolic acid on the pigskin) .
  • the organic extract will contain the glycolic acid and the water will contain the sodium glycolate.
  • the concentration of the sodium glycolate and the glycolic acid on the skin is determined by comparison with standard solutions on the Gas Chromatography and/or Liquid Chromotography using analytic procedure below.
  • Apparatus 2 A suitable Liquid Chromatography (HP)
  • UV Detector UV Detector Column: Phenomenex LUNA 5u C18(2)
  • Glycolic Acid Solution (44% active @ pH 4) (benefit agent in internal aqueous phase) ; Petrolatum (oil phase)
  • petrolatum oil phase
  • EM90 emulsifier
  • Carbopol 980 (Any Carbomer may be used) ;
  • Cationic Polymer e.g., Jaguar
  • Biopolymers Agar, Carragenaan
  • Beaker A In a Beaker A, water-in-oil premix (prepared as noted above) , Brij 58 and borage seed oil were added.
  • Beaker B In Beaker B, water, glycerin, formaldehyde and carbopol 980/cationic polymer/bipolymer were added.
  • Beaker A was removed from heat and Beaker B was added to
  • Stripe B Benefit Agent Stripe
  • Stripe B - Benefit Agent Oil-In Water Emulsion
  • compositions of Example 4 and of the Comparative A were compared for deposition results using protocol set forth previously and results are set forth below:
  • This emulsion is similar to that of Example 4.
  • the surfactant stripe is essentially same (betaine/isethionate) .
  • the benefit agent stripe uses sodium lactate as benefit agent and mineral oil as the oil.

Abstract

The invention provides an at least dual compartment container containing at least one surfactant stripe and at least one multiple emulsion stripe. By dispensing a multiple emulsion stripe, greater deposition, particularly deposition of water soluble benefit agent (e.g., glycolic acid) is achieved than believed possible.

Description

DUAL CHAMBER CLEANSING SYSTEM COMPRISING MULTIPLE EMULSION
The present invention relates to a composition for depositing water soluble benefit agents (e.g., glycolic acid, lactic acid, hydroxy caprylic acid, water soluble vitamins etc. ) in greater amounts than previously possible when using personal wash shower gel type liquids and/or facial cleansers while maintaining good foam stability. Specifically, the invention relates to a dual chamber system in which one composition/stripe comprises a surfactant; and a separate composition/stripe, which is co-dispensed, comprises a multiple emulsion which in turn comprises a benefit agent emulsion (e.g., water soluble glycolic acid in oil) emulsified in a water solution containing additional water soluble benefit agent (e.g., glycerol, PEGs, PPG, etc. )
It is greatly desirable to deposit water soluble benefit agents (e.g., glycolic acid; lactic acid) onto the skin or another substrate.
However, deposition of water soluble benefit agent is extremely difficult to accomplish, particularly from wash- off type products (e.g., shower gels) because the water soluble benefit agent will essentially wash off when the user rinses with water. In general, although there are still problems with shower gel products, it is much easier to deposit a hydrophobic benefit agent (e.g., silicone or petrolatum) than a hydrophilic one. Unexpectedly, the applicants have found that, by forming a multiple emulsion of a water soluble benefit agent and separately dispensing the water soluble benefit agent containing multiple emulsion in one stripe and a surfactant containing composition in another, the applicants have been able to deposit greater amounts of water soluble benefit agent than otherwise achievable (e.g., either through a single stripe cleanser, or through dual stripe cleanser having only oil in water emulsion, rather than the water-in- oil-in-water emulsion of invention) .
The use of separate surfactant and benefit agent stripes is not itself new. U.S. Patent No. 5,612,307 to Chambers et al., for example, teaches a dual chamber package comprising separate surfactant and benefit agent stripe. The benefit agent, however, is a lipophilic benefit agent rather than a water-soluble one, and further is not in the multiple emulsion form of the multiple emulsion stripe of the invention.
Multiple emulsion like those of the invention are taught in the applicants' co-pending application entitled "Stable Multiple Emulsion Composition" to Naser et al . filed on the same date as the subject application, but this reference does not teach the dual chamber dispensing system of the subject invention.
Unexpectedly, the applicants have found that a dual chamber dispenser comprising a surfactant containing stripe on one side and a multiple emulsion containing stripe on the other (wherein the emulsion is a water in oil in water emulsion, and wherein the internal water phase contains at least one water soluble benefit agent) is able to deliver water soluble benefit agent to the skin or other substrate in greater amounts than otherwise possible, i.e., using single stripe, or using different type of emulsion in the two stripe system such as oil in water only.
Specifically, the invention comprises:
- an aqueous liquid cleansing and moisturising composition comprising an at least dual chamber dispenser (in theory more than two stripes may be dispensed, and the invention is not necessarily limited by the number of stripes) comprising: (A) 10 to 99.9% by wt . , preferably 30 to
99.9%, more preferably 50 to 99.9% of a surfactant containing stripe wherein about 1 to 75%, preferably 5 to 70% of said surfactant stripe comprises a surfactant selected from the group consisting of anionic, nonionic, zwitterionic and cationic surfactants, soap and mixtures thereof (water, solute, opacifier, bactericides and other standard ingredients may also be found in the stripe) ; and
(B) 0.1 to 90%, preferably 0.1 to 70%, more preferably 0.1 to 50% by wt . of a multiple emulsion stripe comprising: (1) 1 to 99%, preferably 2 to 90% of said multiple emulsion of a water in oil (Wχ/0) emulsion comprising:
(a) about 1 to 99% of an internal aqueous phase comprising water, optional solute
(0.01 to 30% solute) and optional surfactant (0 to 30%) ;
(b) 0.5 to 99%, preferably 1 to 80% of the emulsion of an oil phase surrounding said internal aqueous phase comprising a non-volatile silicone compound, a volatile hydrocarbon compound, a nonvolatile hydrocarbon compound or a mixture thereof; (c) about 0.1 to 20%, preferably 1 to 15% of a low HLB emulsifier (e.g., HLB under 10) ; and (d) an effective amount (e.g., 0.01 to 40%, preferably 0.05 to 15%) of a topically effective water-soluble compound (e.g., glycolic acid) found in the internal aqueous phase; and
(2) 1 to 99%, preferably 20 to 95% of said multiple emulsion of an external aqueous phase 2 comprising:
(a) 0 to 30%, preferably 0.01 to 5% of a high (10-30) HLB nonionic surfactant (e.g., Brij 58) which may be used to stop oil in the oil phase from leaking out of the W2 phase to form separate oil layer; (b) 0 to 60%, preferably 10 to 50% second topically active compound (e.g., glycerin) ;
(c) optional solute; and (d) 0 to 20% optional cleansing surfactant or surfactants wherein, if anionic, the surfactant is a non-amido surfactant.
As noted, the 2 phase could be nothing but water.
Also, as noted in applicants co-pending application filed on same date, if predominantly anionic (>60%) in W2 phase, a nonionic gum polymer is preferably present in W2 and, if W2 is predominantly amphoteric (>50%) , an anionic gum polymer is preferably present.
The present invention relates to an at least dual chamber dispenser comprising a surfactant containing stripe on one side ( (A) above) and a multiple emulsion containing stripe ((B) above) on the other. The multiple emulsion is a water in oil in water emulsion (W1-O-W2) wherein the internal water phase contains a water soluble benefit agent (e.g., glycolic acid) . Each of the various components is described in greater detail below.
One stripe of the dispenser of the invention is the surfactant stripe (Component A) . The surfactant containing stripe is really not limited in any way and any viable surfactant system may be used, although preferably this will be a "mild" surfactant system. The surface active agent can be selected from any known surfactant suitable for topical application to the human body. As noted, mild surfactants, i.e., surfactants which do not damage the stratum corneum, the outer layer of skin, are particularly preferred.
On preferred anionic surfactant is fatty acyl isethionate of formula :
RCO2CH2CH2SO3
where R is an alkyl or alkenyl group of 7 to 21 carbon atoms and M is a solubilizing cation such as sodium, potassium, ammonium or substituted ammonium. Preferably at least three quarters of the RCO groups have 12 to 18 carbon atoms and may be derived from coconut, palm or a coconut/palm blend.
Another preferred anionic surfactant is alkyl ether sulphate of formula:
RO(CH2CH20)nS03M
where R is an alkyl group of 8 to 22 carbon atoms, n ranges from 0.5 to 10 especially from 1.5 to 8, and M is a solubilizing cation as before.
Other possible anionic surfactants include alkyl glyceryl ether sulphate, sulphosuccinates, taurates, sarcosinates, sulphoacetates, alkyl phosphate, alkyl phosphate esters and acyl lactylate, alkyl glutamates and mixtures thereof. Sulphosuccinates may be monoalkyl sulphosuccinates having the formula:
R102CCH2CH (S03M) CO2 ;
and amino-MEA sulphosuccinates of the formula:
R1ONHCH2CH2θ2CCH2CH (SO3M) C02M;
wherein R ranges for C8-C20 alkyl, preferably C12-C15 alkyl and M is a solubilizing cation.
Sarcosinates are generally indicated by the formula:
R2CON(CH3)CH2C02M,
2 wherein R ranges from C8-C20 alkyl, preferably C12-C15 alkyl and M is a solubilizing cation.
Taurates are generally identified by the formula:
R3C0NR4CH2CH S03M,
wherein R ranges from C8-C20 alkyl preferably C12-C15 alkyl,
R ranges from C1-C alkyl, and M is a solubilizing cation. Harsh surfactants such as primary alkane sulphonate or alkyl benzene sulphonate will generally be avoided.
Suitable nonionic surfactants include alkyl polysaccharides, lactobionamides , ethylene glycol esters, glycerol monoethers, polyhydroxyamides (glucamide) , primary and secondary alcohol ethoxylates, especially the C8-C20 aliphatic alcohols ethoxylated with an average of from 1 to 20 moles of ethylene oxide per mole of alcohol.
If the surfactant comprises soap, the soap is preferably derived from materials with a Cs to C22 substantially saturated carbon chain and, preferably, is a potassium soap with a C12 to Cχ8 carbon chain.
Mixtures of any of the foregoing surfactants may also be used.
The surfactant is preferably present at a level of from 1 to 75 wt.%, preferably 5 to 70 wt . % .
It is also preferable that the composition includes from 0.5 to 15 wt.% of a co-surfactant agent with skin mildness benefits. Suitable materials are zwitterionic surfactants which have an alkyl or alkenyl group of 7 to 18 carbon atoms and comply with an overall structural formula:
Figure imgf000010_0001
1 2 where R is alkyl or alkenyl of 7 to 18 carbon atoms R and
3 R are each independently alkyl, hydroxyalkyl or carboxyalkyl of 1 to 3 carbon atoms; m is 2 to 4; n is 0 or 1;
X is alkylene of 1 to 3 carbon atoms optionally substituted with hydroxyl; and
Y is -CO2 or -S03.
Zwitterionic surfactants within the above general formula include simple betaines of formula:
Figure imgf000010_0002
RJ
and amido betaines of formula:
Figure imgf000010_0003
where m is 2 or 3 . 1 2 3 1
In both formulae R , R and R are as defined previously. R may, in particular, be a mixture of C12 and C1-3 alkyl groups derived from coconut so that at least half, preferably at least three quarters, of the group R has 10 to 14 carbon
2 3 atoms. R and R are preferably methyl.
A further possibility is a sulphobetaine of formula:
Figure imgf000011_0001
J?
or
R CONH(CH2)m fN. (CH2)3S 3
where m is 2 or 3, or variants of these in which -(CH2)3Sθ3- is replaced by
JCH2CHCH2SO3 ■ 1 2 3 R , R and R in these formulae are as defined previously.
A structurant may be added to the phase comprising the surfactant. Suitable materials include swelling clays, for example laponite; fatty acids and derivatives thereof, in particular, fatty acid monoglyceride polyglycol ethers; cross-linked polyacrylates such as Carbopol™ (polymers available from Goodrich) ; acrylates and copolymers thereof; polyvinylpyrrolidone and copolymers thereof; polyethylene imines; salts such as sodium chloride and ammonium sulphate; sucrose esters; gellants; and mixtures thereof.
Of the clays, particularly preferred are synthetic hectorite
(laponite) clay used in conjunction with an electrolyte salt capable of causing the clay to thicken. Suitable electrolytes include alkali and alkaline earth salts such as halides, ammonium salts and sulphates.
The surfactant phase may also comprise a thickening agent, i.e., a material which maintains the viscosity of this phase as the shear rate thereof is increased during use. Suitable materials include cross-linked polyacrylates such as
Carbopol™ polymers available from Goodrich) ; natural gums including alginates, guar, xanthan and polysaccharide derivatives including carboxy methyl cellulose and hydroxypropyl guar; propylene glycols and propylene glycol oleates; salts such as sodium chloride and ammonium sulfate; glycerol tallowates; and mixtures thereof. It should be appreciated that, although there is a separate benefit agent stripe (i.e., the multiple emulsion stripe
W1-O-W2 defined by (B) ) , some benefit agent (e.g., hydrophobic agents such as silicone, petrolatum; or hydrophilic benefit agents or water soluble agents such as polyglycerin) may also be added to the surfactant stripe. Other components which may be used in the surfactant stripe are soluble/salts (e.g., alkali metal chloride), for example, to control viscosity; small amounts of opacifiers (preferably 0.2 to 2%), preservatives (0.2 to 2.0 wt. %) , perfumes (0.5 to 2.0 wt.%) etc.
The separate benefit agent stripe is a multiple emulsion stripe which is similar to the stable emulsion described in " Phase Stable Multiple Emulsion Compositions" to Naser et al., filed on same date as subject application and hereby incorporated by reference into the subject application.
The multiple emulsion composition comprises both a water in oil portion and an external water emulsion surrounding the water in oil emulsion. More specifically, the multiple emulsion comprises:
(1) 1 to 99% of a Wχ/0 emulsion which itself comprises (a) about 1 to 99% internal aqueous phase containing water, 0.01 to 30% optional solute and 0 to 30% optional surfactant; (b) 0.5 to 99% oil phase O surrounding said internal aqueous phase comprising a non- volatile silicone compound, a volatile hydrocarbon compound, a non-volatile hydrocarbon compound or mixtures thereof;
(c) about 0.1 to 20% of a low HLB emulsifier; and
(d) topically effective amount of a water-soluble benefit agent in the internal water phase; and
(2) 1 to 99% of an external aqueous phase W2 which comprises :
(a) 0 to 30%, preferably 0.01 to 5% of high HLB nonionic surfactant emulsifier surfactant;
(b) 0-60% of a second topically active compound;
(c) optional solute; and
(d) 0-20% optional cleansing surfactant or surfactants wherein, if anionic, the surfactant is a non-amido surfactant.
The water phase of the χ/0 part of emulsion will generally comprise droplets with an internal aqueous phase containing water, optional solute (preferably 0.01 to 30%) and a topically active compound (e.g., glycolic and/or lactic acid) ; and an oil phase surrounding said internal aqueous phase. Droplets may range from 0.1 to about 10 microns and may be enveloped by a membrane or film comprising oil and low HLB emulsifier.
The WiO emulsion is present in an amount 1-99%, preferably 2 to 90%, more preferably 5 to 90%, most preferably 10 to 70% by wt . of multiple emulsion 1-O- 2. As noted, i aqueous phase comprise 1 to 99% by wt . of the emulsion with small amounts of oil and low HLB emulsifier separating Wi and W2. The water phase may comprise water, solute and water-soluble topically active compound (oil soluble active may also be in oil phase) . It may also comprise additional active compounds and/or optional water soluble compounds providing desired aesthetic or functional effect (e.g., perfume).
The Wi phase may comprise 1-99%, preferably 10-95% of Wi/O emulsion, more preferably 25 to 95% of emulsion.
The topically active compound may enter the water or oil phase depending on solubility (e.g., water soluble compound in water phase and oil soluble in oil phase) .
As used herein, the term "water soluble" means water soluble or water dispersible. A water soluble compound has a water solubility of at least 0.1 g (grams) per 100 ml (milliliters) of water and forms a true solution. A water soluble compound can be inherently water soluble or can be made water soluble by the addition of a solubilizing compound, such as a coupling agent, a co-surfactant, or a solvent. A water dispersible compound remains dispersed in water for at least the time period necessary to manufacture the primary W /0 emulsion, i.e., at least about one hour. In addition, the topically active compound can be incorporated into the external aqueous phase W2 to achieve enhanced efficacy.
The topically active compound therefore can be one of, or a combination of, a cosmetic compound, a medicinally active compound or any other compound that is useful upon topical application to the skin or hair. Such topically active compounds include, but are not limited to, hair conditioners (e.g., water soluble quaternary ammonium compounds, alkoxylated and nonalkoxylated fatty amines, dimethicone copolyols, cationic polymers etc.), skin conditioners (e.g., humectants such as glucose, glycerin, propylene glycol, amino acids, vitamins, amino functional silicones, etc.), hair and skin cleansers, hair fixatives, hair dyes, hair growth promoters, deodorants (e.g., organic and inorganic salts of aluminum, zirconium, zinc and mixtures thereof) , skin care compounds, permanent wave compounds, hair relaxers, hair straighteners, antibacterial compounds, antifungal compounds, anti-inflammatory compounds, topical anesthetics, sunscreens and other cosmetic and medicinal topically effective compounds (e.g., antifungal, antibacterial) .
Sufficient water is present in the aqueous phase such that the aqueous phase comprises about 1% to about 95% by weight of the primary emulsion. Total water present in the 1-O- 2 multiple emulsion composition is about 30% to about 99.9%, and typically about 40% to about 95%, by weight of the composition. Among optional ingredients which may be included in the internal aqueous phase are included solutes. Among solutes which may be added are salts such as alkali metal chloride. Solute added to the internal aqueous phase may comprise 0 to 30% by wt., preferably 0.1-10% by wt .
It is also possible to add surfactant to the internal aqueous phase though this is added generally to the external
W2 phase, if it is to be added at all. The surfactant can be any of the surfactants discussed in connection with the 2 phase below.
The internal aqueous phase also can include optional ingredients traditionally included in topically applied compositions. These optional ingredients include, but are not limited to, dyes, fragrances, preservatives, antioxidants, detackifying agents, and similar types of compounds. The internal phase may also include polyalkylene oxide components. These may be particularly useful for incorporating certain hydrophilic benefit agents (e.g., salicylic acid) which may otherwise be difficult to add to the internal aqueous phase. The optional ingredients are included in the internal aqueous phase of the primary emulsion in an amount sufficient to perform their intended function.
The oil phase may be volatile (except for silicone) or nonvolatile . A volatile oil may comprise a volatile hydrocarbon oil which evaporates during the process of drying skin or hair, and thereby releases the internal aqueous Wi phase, which includes the first topically active compound to contact the skin or hair. This oil preferably should contain no volatile silicone since volatile silicones tend to destabilize the multiple emulsion.
In one embodiment, the oil may comprise a combination of a volatile oil (except for silicone) and a .nonvolatile oil.
In this embodiment, an oil can be designed to evaporate at a pre-selected temperature and provide a controlled release of the first topically active compound at the pre-selected temperature. Pre-selected temperatures are those encountered during normal hair drying, provided by a hair dryer, or provided by a curling iron.
As previously stated, the oil also can include a water insoluble topically active compound in a sufficient amount to impart a particular functional or aesthetic effect (e.g., emolliency) , as long as the topically active compound does not adversely affect the W1-O-W2 multiple emulsion composition (e.g., does not impart emulsion instability).
Volatile hydrocarbon compounds incorporated into the primary emulsion include, for example, isododecane and isohexadecane, i.e., PERMETHYL 99A, PERMETHYL 101A and PERMETHYL 102A, available from Presperse, Inc., South Plainfield, N.J. Other exemplary volatile hydrocarbon compounds are depicted in general structural formula (I), wherein n ranges from 2 to 5.
Figure imgf000019_0001
Another exemplary volatile hydrocarbon compound is ISOPAR M
(a C13-C1 isoparaffin available from Exxon Chemical Co.,
Baytown, Tex) . Preferably, the volatile hydrocarbon is less than 50% unsaturated.
As previously stated, the oil also can be a non-volatile oil. The non-volatile oil comprises a non-volatile silicone compound, a non-volatile hydrocarbon, or a mixture thereof. Preferably, the non-volatile oil comprises compounds which contain less than 50% unsaturation. The non-volatile oil does not evaporate from the skin or hair. The first topically active compound therefore is released by rubbing the skin or hair to rupture the primary Wχ/0 emulsion. A non-volatile oil phase has a boiling point at atmospheric pressure of greater than about 250°C.
Exemplary non-volatile silicone compounds include a polyalkyl siloxane, a polyaryl siloxane or a polyalkylaryl siloxane. Mix of these non-volatile silicone compounds also are useful.
The non-volatile oil also can comprise a non-volatile hydrocarbon compound, such as mineral oil, petrolatum, sunflower seed oil, canola oil or miters thereof. Other exemplary non-volatile hydrocarbon compounds that can be incorporated into the oil phase include, but are not limited to, a branched 1-decene oligomer, like 1-decene dimer or a polydecene.
The oil also optionally can comprise (1) an oil, such as jojoba oil, wheat germ oil or purcellin oil; or (2) a water insoluble emollient, such as, for example, an ester having at least about 10 carbon atoms, and preferably about 10 to about 32 carbon atoms.
Suitable esters include those comprising an aliphatic alcohol having about eight to about twenty carbon atoms and an aliphatic or aromatic carboxylic acid including from two to about twelve carbon atoms, or conversely, an aliphatic alcohol having two to about twelve carbon atoms with an aliphatic or aromatic carboxylic acid including about eight to about twenty carbon atoms. The ester is either straight chained or branched. Preferably, the ester has a molecular wt . of less than about 500. Suitable esters therefore include, for example, but are not limited to:
(a) aliphatic monohydric alcohol esters (e.g., isopropyl isostearate, cetyl acetate, cetyl stearate) ; myristyl propionate, isopropyl myristate, isopropyl palmitate, cetyl acetate, cetyl propionate, cetyl stearate,
(b) aliphatic di- and tri-esters of polycarboxylic acids, (e.g., diisopropyl adipate) ;
(c) aliphatic polyhydric alcohol esters (e.g., propylene glycol dipelargonate) ; and
(d) aliphatic esters of aromatic acids, (e.g., C12-C15 alcohol esters of benzoic acid) .
The oil phase of the present invention also may include about 0.1% to about 30%, and preferably about 0.1% to about 15%, on the weight of the oil of a low HLB emulsifier.
The low HLB emulsifier may comprise a silicon-free surfactant, or a blend of silicon-free surfactants, having an HLB value of about 10 or less (i.e., an HLB value of about 0.1 to about 10), an oil-soluble silicon-based surfactant, an oil-soluble polymeric surfactant, or mixtures thereof. Preferably, the silicon-free surfactant or surfactant blend has an HLB value of about 1 to about 7. To achieve the full advantage of the present invention, the silicon-free surfactant or surfactant blend has an HLB value of about 3 to about 6. The term "oil-soluble" as used herein means a compound having a solubility of at least 0.1 g per 100 ml of oil phase to form a true solution.
The HLB value of a particular silicon-free surfactant can be found in McCutcheon ' s Emulsifiers and Detergen ts , North
American and In terna tiona l Edi tions , MC Publishing , Glen Rock, NJ (1993) (hereinafter McCutcheon ' s) . Alternatively, the HLB value of a particular surfactant can be estimated by dividing the weight percent of oxyethylene in the surfactant by five (for surfactants including only ethoxy moieties). In addition, the HLB value of a surfactant blend can be estimated by the following formula:
HLB = (wt.% A) (HLBA) + (wt.% B) (HLBB) ,
wherein wt . % A and wt . % B are the weight percent of surfactants A and B in the silicon-free surfactant blend, and HLBA and HLBB are the HLB values for surfactants A and B, respectively.
Low HLB surfactant can be a silicone-based surfactant or silicone-free surfactant.
Exemplary classes of silicon-free nonionic surfactants include, but are not limited to, polyoxyethylene ethers of fatty (Cg-C22) alcohols, polyoxyethylene/polyoxypropylene ethers of fatty (C6-C22) alcohols, ethoxylated alkylphenols, polyethylene glycol ethers of methyl glucose, polyethylene glycol ethers of sorbitol, and mixtures thereof.
Exemplary silicon-free nonionic surfactants are the ethoxylated alcohols having an HLB value of about 0.1 to about 10. An especially preferred ethoxylated alcohol is laureth-1, i.e., lauryl alcohol ethoxylated with an average of one mole of ethylene oxide. Other suitable ethoxylated alcohols include laureth-2, laureth-3 and laureth-4. Numerous other nonionic surfactants having an HLB of about 0.1 to about 10 are listed in McCutcheon' s at pages 229-236, incorporated herein by reference. Other exemplary silicon- free nonionic surfactants having an HLB value of about 0.1 to about 10 include, but are not limited to, the ethoxylated nonylphenols, ethoxylated octylphenols, ethoxylated dodecylphenols, ethoxylated fatty (C6-C22) alcohols having four or fewer ethylene oxide moieties, oleth-2, steareth-3, steareth-2, ceteth-2, oleth-3,and mixtures thereof.
The emulsifier can also comprise a silicon-free surfactant blend having an HLB value of about 1 to about 10. The blend is a mixture of a sufficient amount of a surfactant having allow HLB value, i.e., about 0.1 to about 10, and a sufficient amount of a surfactant having a higher HLB value, i.e., about 1 to greater than about 10, such that the surfactant blend has an HLB value of about 1 to about 10. Exemplary, but non-limiting, nonionic surfactants having a high HLB value are listed in McCutcheon ' s at pages 236-246, incorporated herein by reference.
A preferred silicone-free surfactant is PEG-30 dipolyhydroxystearate .
An exemplary oil-soluble silicon-based surfactant is a dimethicone copolyol, which is a dimethylsiloxane polymer having polyoxyethylene and/or polyoxypropylene side chains, such as DOW CORNING 322C FORMULATION AID, available from Dow Corning Co., Midland, Mich. The dimethicone copolyol has about 15 or fewer ethylene oxide and/or propylene oxide monomer units, in total, in the side chains. Dimethicone copolyols conventionally are used in conjunction with silicones because the silicon-containing surfactants are extremely soluble in a volatile or a non-volatile silicone compound, are extremely insoluble in water, and have a low skin irritancy potential.
Another exemplary, but non-limiting, oil-soluble, silicon- based surfactant is an alkyl dimethicone copolyol, such as cetyl dimethicone copolyol available commercially as ABIL(R) EM 90 from Goldschmidt Chemical Corporation, Hopewell, Va . The alkyl dimethicone copolyols have the structure:
Figure imgf000024_0001
wherein:
p is a numeral from 7 through 17; q is a numeral from 1 through 100; m is a numeral from 1 through 40; n is a numeral from 0 through 200; and PE is (C2H4O) a (C3H6O) _H having a molecular weight of about 250 to about 2000, wherein a and b are selected such that the weight ratio of C2H4θ/C3H60 is from 100/0 to20/80.
The emulsifier may also be an oil-soluble polymeric surfactant. Polymeric surfactants capable of forming water- in-oil emulsions completely cover the surface of the water droplet, are firmly anchored at the oil-water interface, the external oil phase is a good solvent for the stabilizing portion of the polymeric surfactant, and the thickness of the polymer layer on the oil side of the interface is sufficient to ensure stability. These surfactants may include ethoxy, propoxy and/or similar alkylene oxide monomer units, e.g., butoxy.
The oil-soluble polymeric surfactants act as surfactants and are not physically or chemically cross-linked in solution. The oil-soluble polymeric surfactants therefore are differentiated from polymeric gelling agents such as polyacrylic acid or polymethacrylic acid.
Accordingly, exemplary oil-soluble polymeric surfactants include, but are not limited to, polyoxyethylene- polyoxypropylene block copolymers, and similar polyoxyalkylene block copolymers. The oil-soluble block copolymers typically have less than about 20% by weight of ethylene oxide. Specific non-limiting oil-soluble polymeric surfactants include Poloxamer 101 , Poloxamer 105, PPG-2- Buteth-3, PPG-3-Butech-5, PPG-5-Butech-7 , PPG-7-Butech-10, PPG-9-Buteth-12, PPG-12-Buteth-16, PPG-15-Buteth-20, PPG-20- Buteth-30, PPG-24-Buteth-27, PPG-28-Buteth-35, and PEG-15 Butanediol. Other useful oil-soluble polymeric surfactants are polyamines, i.e., polyoxyethylene-polyoxypropylene block copolymers of ethylene diamine, having less than about 40% by weight ethylene oxide.
In accordance with an important feature of the present invention, the hydrophobic moiety of a silicon-free surfactant, silicon-containing surfactant or polymeric surfactant is sufficiently soluble in the oil phase such that a sufficient amount of the surfactant is present in the oil phase to stabilize the primary Wχ/0 emulsion.
In one embodiment when the oil phase comprises a silicone compound, the surfactant phase comprises either a silicon- based surfactant, a silicon-free surfactant having a hydrophobic moiety preferably containing about ten to about fourteen carbon atoms, an oil-soluble polymeric surfactant, or a mixture thereof. If the hydrophobic moiety of the silicon-free surfactant is saturated and includes more than about 14 carbon atoms, the silicon-free surfactant is insoluble in the silicone phase and the primary χ/0 emulsion is unstable. If the hydrophobic moiety includes less than about 10 carbon atoms, the primary Wχ/0 emulsion has a tendency to coalesces i.e., the emulsion droplets fuse to form large droplets.
The amount of surfactant phase necessary to provide a primary emulsion of desired W /0 droplet diameter varies with the amount of aqueous phase in the primary emulsion and is easily determined by those skilled in the art.
One particularly preferred emulsifier is cetyl dimethicone copolyol.
The external aqueous phase ( 2) of the W1-O- 2 multiple emulsion may comprise an isotropic mixture of surfactants phase (as opposed to lamellar phase of U.S. Patent No. 5,656,280), if surfactants are present. The phase may also comprise 0-60% by wt . of phase, preferably 10-50% of a second topically active compound, similar to or different from the first topically active compound and optional solute and optional (preferably 0.01 to 10%) of a stabilizing natural gum polymer. If present, surfactant may be a non- amido anionic or all amphoteric or mixtures of the two. Surfactant may be absent, but will typically comprise 2-80% of aqueous phase.
This external phase may comprise a mixture of anionic and/or nonionic (or other) surfactants in combination with amphoteric surfactants wherein anionic/nonionic comprises 1 to 99% of the surfactant system and amphoteric comprises 1 to 99% of the surfactant system, i.e., one should not ideally be present to the exclusion of the other.
In general, surfactant can be any of the surfactants described in connection with the surfactant stripe phase. More specifically, if surfactant is entire or majority (>60%) anionic, it is preferred nonionic gum polymer be used.
Particularly soluble and dispersible in anionic surfactants and anionic rich surfactant systems are the nonionic seed polysaccharides. One such stabilizer is guar gum, which is structurally composed of a straight chain of D-mannose with a D-galactose side chain on approximately every other mannose unit. The usual ratio of mannose to galactose is approximately 2:1 and molecular weights are usually on the order of 100,000 to 1,000,000. Another useful stabilizer is locust bean gum, a galactomannan consisting of a main chain of D-mannose units with single galactose side chains on approximately every fourth unit. As with guar gum, approximate molecular weights are between 100,000 and 1,000,000.
In systems where the external surfactant W2 is comprised entirely of or contains a majority (50% or higher) of amphoteric surfactant, an anionic gum polymer is preferred. These can be seaweed polysaccharides, exudate polysaccharides, or microbial polysaccharides.
A preferred anionic seaweed polysaccharide is carrageenan, or "Irish moss," a complex mixture of sulfated polysaccharides. Carrageenan is a mixture of galactans that carry varying proportions of half-ester sulfate groups linked to one or more of the hydroxyl groups of the galactose units, which are joined by alternating α-1,3 and β-1,4 glycosidic linkages. The molecular weight usually ranges from 100,000 to 1,000,000.
A preferred anionic exudate polysaccharide is gum tragacanth, a complex mixture of acidic polysaccharides containing galacturonic acid, galactose, fucose, xylose, and arabinose. Another preferred anionic exudate polysaccharide is gum karaya, a partially acetylated high molecular weight polysaccharide which contains L-rhamnose, D-galactose, D- galacturonic acid, and D-glucuronic acid residues.
Most preferred in amphoteric surfactants or amphoteric rich surfactant systems are microbial anionic hetero- polysaccharide gums, most preferably xanthan gum. The primary structure of these microbial gums contains two glucose units, two mannose units, and one glucuronic acid unit .
According to the invention, the benefit agent stripe (with multiple emulsion) and surfactant stripe are separate but combinedly dispensable from a packaging means and typically a single packaging means. Such a packaging means includes those systems which comprise two separate compartments. Ensuring that the surfactant and benefit agent are separate can be achieved in a variety of ways. Packaging of the composition such that the surfactant and benefit agent are presented in separate compartments or in separate domains within the packaging; including encapsulation of the benefit agent; and by processing of the composition by co-extrusion to produce a striped product in which individual stripes contain either the surface active agent or benefit agent. Compositions of the invention may be formulated as products for washing the skin, for example, bath or shear gels, hand washing compositions or facial washing liquids; pre- and post-shaving products; rinse-off, wipe-off and leave-on skin care products; products for washing the hair and for dental use.
The compositions of the invention will generally be pourable liquids or semi-liquids, e.g., pastes and will have a viscosity in the range of 250 to 100,000 mPas measured at a shear rate 10s and 25°C in a Haake rotoviscometer RV20.
When the product is formulated as a shower gel the viscosity will generally be in the range 200 to 15000 mPas, preferably
500 to 15,000 measured at a shear rate 10s x and 25°C.
When the product is formulated as a facial wash product the viscosity will generally be in the range 3000 to 100,000 mPas measured at a shear rate 10s and 25°C.
Other typical components of such compositions include opacifiers, preferably 0.2 to 2.0 wt.%; preservatives, preferably 0.2 to 2.0 wt.% and perfumes, preferably 0.5 to 2.0 wt.%.
Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts or ratios of materials or conditions or reaction, physical properties of materials and/or use are to be understood as modified by the word "about" .
Where used in the specification, the term "comprising" is intended to include the presence of stated features, integers, steps, components, but not to preclude the presence or addition of one or more features, integers, steps, components or groups thereof.
The following examples are intended to further illustrate the invention and are not intended to limit the invention in any way.
All percentages used, unless indicated otherwise, are intended to be percentages by weight.
Glycolic Acid and Sodium Glycolate Deposition Protocol
Procedure for Analyzing the Deposition of Glycolic Acid and Sodium Glycolate from Cleansers by Gas Chromatography (GC)
Test Procedure (Pigskin) :
Fresh Piglet skin (4-5 weeks old, male, white, no nipples and shaved) is used for the deposition studies. The skin is cut into -12 cm x 5 cm pieces which are stretched and pinned onto a support. The surface of the skin is wetted with 250 ml water and 1 gram of cleanser is applied to the wet surface (0.5 gram benefit stripe and 0.5 gram of surfactant phase) . The skin is then washed by hand for 30-60 seconds, rinsed three times with 250 ml aliquots of water and patted dry with Kimwipe paper towel.
A glass/plastic cylinder 3.3 cm in diameter is then placed in close contact with the skin surface and the skin is extracted three times with 3 ml aliquots of organic solvent (ethanol, acetone or tetrahydrofuran) followed by another three times with 3 ml aliquots of distilled water. The organic solvent extracts are combined. The same is done for the water extracts. (The water and/or organic solvent extractions can be repeated several times depending on the concentration of sodium glycolate or glycolic acid on the pigskin) . The organic extract will contain the glycolic acid and the water will contain the sodium glycolate.
Three sites are extracted on each of three pieces of skin for each formulation. The concentration of the sodium glycolate and the glycolic acid on the skin (in μg/cm2) is determined by comparison with standard solutions on the Gas Chromatography and/or Liquid Chromotography using analytic procedure below.
Analytical Procedure
Apparatus 1:
A suitable Gas Chromatography (HP 5890 series II perhaps)
Sil-prep from Alltech (part #18013)
Gas Chromatography Setting: Detector: Flame Ionization Detector Column: HP-1 100%-Polydimethylsiloxane,
Column length 25.9 m,
Inside diameter 0.2 mm, Film thickness 0.33 mm
Injector Volume 4.0 uL-5.0uL Gases: Helium (carrier) , Hydrogen and Air
(Flame)
Flow rate: Total flow rate: Detector temp. : 250°C Injector temp. : 250°C Oven temperature: Set point 50°C, limit 300°C Run time: 14.6 minutes
Oven Temperature Profile;
Initial temp. 50°C Initial time: 0.0 Rate: 25C/minute
Final temp. : 290°C Final time: 14.6 minutes
Standards:
Solutions at 4000, 2000, 1000, 500, 250, 125, 62.5, 31.3, 15.6, 7.8 μg/ml are prepared. Glycolic acid in organic solvent. Sodium glycolate in water.
Apparatus 2: A suitable Liquid Chromatography (HP)
Liquid Chromatography Settings
Detector: UV Detector Column: Phenomenex LUNA 5u C18(2)
Injector volume: 5.0 uL-50.0 uL Mobil phase: 97% 20nM Potassium Phosphate @ pH 2.3:3% Methanol
Flow rate: 0.7 ml/minute Temperature: 25°C Run time: 30 minutes
Standards:
Solutions at 4000, 2000, 1000, 500, 250, 125, 62.5, 31.3, 15.6, 7.8 μg/ml are prepared.
EXAMPLES
Example 1 - Preparation of Water-Oil-Water Benefit Stripe
Preparation of Wi/O Phase of W1-O-W2 Multiple Emulsion (Glycolic Acid Premix) Used as Benefit Stripe
Ingredients Glycolic Acid Solution (44% active @ pH 4) (benefit agent in internal aqueous phase) ; Petrolatum (oil phase)
Abil EM90 Goldschmidt (cetyl dimethicone copolyol low HLB emulsifier) ;
Preparation
In a beaker, petrolatum (oil phase) and EM90 (emulsifier) were added. Contents were heated to ~65-70°C (allowing petrolatum to melt) . Contents were stirred at approximately 800-900 rpms . Whilst stirring, glycolic acid solution (premix) was added dropwise. After addition of glycolic acid, the mixture was homogenized at 10,000 rpm for 10-15 minutes and mixture was cooled overnight.
Preparation of W1-O-W2 Benefit Stripe
Ingredients
Water;
Glycerin (optional);
Carbopol 980 (Any Carbomer may be used) ;
Cationic Polymer (e.g., Jaguar) - Biopolymers (Agar, Carragenaan) ;
Formaldehyde/Glydant II
Brij 58; (high HLB nonionic used in W2 phase);
Borage Seed Oil (for oil phase);
2M NaOH - Water-in-Oil (Glycolic Acid) Premix (Prepared as noted above) Preparation
Beaker A: In a Beaker A, water-in-oil premix (prepared as noted above) , Brij 58 and borage seed oil were added.
Contents were heated to ~65-70°C. Ingredients were stirred well .
Beaker B: In Beaker B, water, glycerin, formaldehyde and carbopol 980/cationic polymer/bipolymer were added.
Contents were stirred at ~700 rpm until Carbopol 980 was fully dispersed in aqueous solution. The mixture was heated to ~65-70°C.
Beaker A was removed from heat and Beaker B was added to
Beaker A. Contents were mixed till homogenous, 2M NaOH was added and mixed for 30-40 minutes @ 500 rpms. The contents were cooled overnight.
Example 2
Preparation of Benefit Agent Premix
Ingredients
Glycolic Acid Solution (44% active @ pH 4);
Water;
NaOH @ 50%;
Glycolic Acid @ 99.0%; - Carbomer Preparation
Water was added to a beaker. Glycolic acid was added and stirred until glycolic acid had dissolved. Glycolic acid solution was cooled to 0°C. NaOH was slowly added (drop- wise) . After addition of NaOH, ingredients were cooled to room temperature. Carbomer was added to solution slowly, stirring rapidly until Carbomer was fully dispersed. The solution became viscous.
Example 3
Following is an example of a stripe which was prepared to be used as surfactant stripe phase ( (A) ) :
Figure imgf000037_0001
Example 4
The following W-O-W2 Petrolatum Stripe and Base (Central Base, Stripe A) were prepared:
Stripe A - Base
Figure imgf000038_0001
Stripe B - Benefit Agent Stripe
Figure imgf000038_0002
*In general in both base and stripe phases, levels come out as half of the amount when dispersed. Thus, 20% glycolic in benefit agent stripe is dispersed as 10% glycolic when out of the container.
Comparative A (Oil-In-Water Benefit Stripe)
The following dual stripe composition was also prepared but, in contrast to Example 4, the benefit gel stripe was not W- 0-W2 stripe with 10% glycolic acid but an oil-in-water stripe with 10% glycolic. Stripe A - Base
Figure imgf000039_0001
Stripe B - Benefit Agent (Oil-In Water Emulsion)
Figure imgf000039_0002
Benefit Agent in Comparative contains no glycerin.
Comparative B (Single Cleanser)
The following single cleanser system was prepared and was used in Example 5 set forth below: 19 -
Figure imgf000040_0001
Example 5
Using the compositions of Example 4 and of the Comparative A (dual cleanser where glycolic acid is directly in water phase) , these were compared for deposition results using protocol set forth previously and results are set forth below:
O/W Composition W/OW Composition
32μg/cm 200 μg/cm
These paragraphs clearly show that a much greater amount of glycolic acid was deposited from multiple W/OW emulsion system than from single O / emulsion system.
Example 6
The applicants also compared deposition from W/O/W emulsion system from dual stripe cleanser system compared to deposition from a single stripe cleanser as set forth in Comparative B. These results are as follows: Single Stripe Dual Stripe with W/O/W Multiple Emulsion in Benefit Stripe
0.5 μg/cm 200 μg/cm
These paragraphs clearly show that a much greater amount of glycolic acid was deposited from multiple W/O/W emulsion system than from single system.
Example 7
The following multiple emulsion was also prepared using a surfactant stripe (Stripe A) and benefit agent stripe (Stripe B) as noted below:
Stripe A - Surfactant Base
Ingredient Active in Stripe
Cocamidopropyl Betaine 15.6
Sodium Laureth Sulfate 10.4
Deposition Polymer (Cationic polymer 0.9
Water 73.1 Stripe B - Benefit Agent W1/OW2 Stripe
Ingredient % Active in Stripe
Mineral Oil (Light) 14.4 Sodium Lactate 7
Sodium Chloride 4.2
Cetyl Dimethicone Copolyol 3.6 Cocamidopropyl Betaine 2.4
Sodium Laureth Sulfate 1.6 Water 66.8
This emulsion is similar to that of Example 4. The surfactant stripe is essentially same (betaine/isethionate) . The benefit agent stripe, however, uses sodium lactate as benefit agent and mineral oil as the oil.
This example shows that many different benefit agents can be used as part of the multiple emulsion.

Claims

1. An aqueous liquid cleansing and moisturizing composition comprising:
(A) 10 to 99.9% by wt . of a surfactant stripe comprising 1 to 75% by wt . of a surface active agent selected from anionic, nonionic, zwitterionic and cationic surface active agents, soap and mixtures thereof; and
(B) 0.1 to 90% by wt . of a benefit agent stripe comprising a multiple emulsion where said multiple emulsion comprises:
(1) . 1 to 99% of said multiple emulsion of a water-in-oil emulsion comprising:
(a) 1 to 99% of an internal aqueous phase containing water, optional solute and optional surfactant;
(b) 0.5 to 99% at an oil phase surrounding an internal aqueous phase comprising a non-volatile silicone compound, a volatile hydrocarbon compound, a nonvolatile hydrocarbon or a mixture thereof; (c) 0.1 to 20% of a surfactant emulsifier having HLB of below 10; and (d) a topically effective amount of a water- soluble benefit agent in the internal aqueous phase; and (2) 1 to 99% of an external aqueous emulsion comprising 0 to 30% nonionic surfactant with HLB of 10-30 surfactant, 0-60% topically active compound, optional solute, and 0-20% cleansing surfactant or surfactant.
2. A composition according to claim 1, wherein the surfactant of (A) comprises 5 to 70% of the stripe.
3. A composition according to claim 1 or claim 2, wherein benefit agent can be added to surfactant Stripe (A) .
4. A composition according to any of the preceding claims, wherein the water-in-oil emulsion is 2 to 90% of the 1-O-W2 emulsion.
5. A composition according to any of the preceding claims, wherein the water-in-oil emulsion comprises 0.1 to 10% by wt . solute.
6. A composition according to any of the preceding claims, wherein the oil phase of the water-in-oil emulsion encapsulates internal aqueous phase to form droplets of about 5 to about 1000 μ.
7. A composition according to any of the preceding claims wherein emulsifier having HLB below 10 comprises 0.1 to 15% of the oil phase.
8. A composition according to claim 7, wherein the emulsifier is a dimethicone copolyol.
9. A composition according to any of the preceding claims, wherein topically effective compounds in the water-in-oil emulsion comnprise glycolic acid.
10. A composition according to any of the preceding claims, wherein the external aqueous phase comprises 20-95% multiple emulsion.
11. A composition according to any of the preceding claims, wherein if cleansing surfactant (B) (2) is present, it is non-amido surfactant.
12. A composition according to any of the preceding claims, wherein the surfactant system of (B) (2) is greater than 60% anionic surfactant and nonionic gum polymer is present.
13. A composition according to any of claims 1-12, wherein the surfactant of (B) (2) is greater than 50% amphoteric surfactant and anionic gum polymer is present.
PCT/EP2000/009762 1999-10-22 2000-10-04 Dual chamber cleansing system comprising multiple emulsion WO2001030308A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002385718A CA2385718A1 (en) 1999-10-22 2000-10-04 Dual chamber cleansing system comprising multiple emulsion
AU10217/01A AU1021701A (en) 1999-10-22 2000-10-04 Dual chamber cleansing system comprising multiple emulsion
JP2001532728A JP2003512408A (en) 1999-10-22 2000-10-04 Dual chamber cleansing system containing multiple emulsions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/425,699 US6268322B1 (en) 1999-10-22 1999-10-22 Dual chamber cleansing system, comprising multiple emulsion
US09/425,699 1999-10-22

Publications (1)

Publication Number Publication Date
WO2001030308A1 true WO2001030308A1 (en) 2001-05-03

Family

ID=23687668

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/009762 WO2001030308A1 (en) 1999-10-22 2000-10-04 Dual chamber cleansing system comprising multiple emulsion

Country Status (5)

Country Link
US (1) US6268322B1 (en)
JP (1) JP2003512408A (en)
AU (1) AU1021701A (en)
CA (1) CA2385718A1 (en)
WO (1) WO2001030308A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004026276A1 (en) * 2002-09-20 2004-04-01 The Procter & Gamble Company Striped liquid personal cleansing compositions containing a cleansing phase and a separate benefit phase
US6758411B2 (en) 2002-08-09 2004-07-06 S. C. Johnson & Son, Inc. Dual bottle for even dispensing of two flowable compositions
WO2004094582A1 (en) * 2003-04-16 2004-11-04 Reckitt Benckiser (Uk) Limited Multiple emulsion cleaning compositions
US8840871B2 (en) 2008-07-28 2014-09-23 The Procter & Gamble Company Multiphase personal care composition with enhanced deposition

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR040600A0 (en) * 2000-09-27 2000-10-19 Chemeq Ltd Polymeric formulation
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
JP4601031B2 (en) * 2001-03-16 2010-12-22 株式会社資生堂 W / O / W emulsified cosmetics
DE10147049A1 (en) * 2001-09-25 2003-04-10 Beiersdorf Ag Use of surfactants with a quotient of hemolysis value and denaturation index of greater than or equal to 1 to achieve or increase the selectivity of cleaning preparations
US6673755B2 (en) 2002-01-16 2004-01-06 The Procter & Gamble Company Personal cleansing compositions containing cleansing and skin active phases separated by one or more packaging barriers
WO2003066016A1 (en) * 2002-02-08 2003-08-14 The Procter & Gamble Company Rinse-off skin conditioning compositions
MXPA05004808A (en) * 2002-11-04 2005-07-22 Procter & Gamble Striped liquid personal cleansing compositions containing a cleansing phase and a separate benefit phase with improved stability.
US20070137042A1 (en) * 2005-12-20 2007-06-21 Focht Heather L Shaving kit, article of commerce and a method of shaving comprising a personal care composition
US20040166083A1 (en) * 2003-02-26 2004-08-26 The Andrew Jergens Company Personal care water-in-oil emulsion products
CN100558338C (en) * 2003-05-01 2009-11-11 宝洁公司 By cleansing phase and the striped liquid personal cleansing compositions that comprises the separate benefit phase composition of High Internal Phase Emulsion
CN1780601B (en) * 2003-05-01 2010-05-12 宝洁公司 Visually distinctive multiple liquid phase compositions
US20040223991A1 (en) * 2003-05-08 2004-11-11 The Procter & Gamble Company Multi-phase personal care composition
US20050090414A1 (en) * 2003-10-23 2005-04-28 Sarah Rich Color changing hand soap composition
US20050143268A1 (en) * 2003-11-14 2005-06-30 The Procter & Gamble Company Personal care composition containing a cleansing phase and a benefit phase
US20050143269A1 (en) * 2003-12-24 2005-06-30 Wei Karl S. Multi-phase personal cleansing compositions comprising a lathering cleansing phase and a non-lathering structured aqueous phase
US8951947B2 (en) * 2003-12-24 2015-02-10 The Procter & Gamble Company Multi-phase personal cleansing compositions comprising a lathering cleansing phase and a non-lathering structured aqueous phase
US8314054B2 (en) * 2004-02-27 2012-11-20 The Procter & Gamble Company Mild multi-phased personal care composition
JP2007523947A (en) * 2004-02-27 2007-08-23 ザ プロクター アンド ギャンブル カンパニー Hypoallergenic body wash
JP2007523948A (en) * 2004-02-27 2007-08-23 ザ プロクター アンド ギャンブル カンパニー Hypoallergenic body wash
US7662855B2 (en) * 2004-05-11 2010-02-16 Imaginative Research Associates, Inc. Retinoid solutions and formulations made therefrom
US20050276768A1 (en) * 2004-06-14 2005-12-15 Karl Shiqing Wei Multi-phased personal care composition
WO2006010090A1 (en) * 2004-07-09 2006-01-26 The Procter & Gamble Company Multi-phased personal care composition
ZA200701006B (en) * 2004-08-04 2008-08-27 Unilever Plc Improved detergent composition with benefit agents
US7666825B2 (en) 2004-10-08 2010-02-23 The Procter & Gamble Company Stable, patterned multi-phased personal care composition
US7531497B2 (en) 2004-10-08 2009-05-12 The Procter & Gamble Company Personal care composition containing a cleansing phase and a benefit phase
US20060079420A1 (en) * 2004-10-08 2006-04-13 Wagner Julie A Multi-phase personal cleansing composition
US7527077B2 (en) * 2005-02-25 2009-05-05 The Procter & Gamble Company Multi-phase personal care compositions, processes for making and providing, and articles of commerce
MX2007007150A (en) * 2005-03-21 2007-08-14 Procter & Gamble Multi-phase personal care composition comprising visually distinct phases.
WO2006113118A1 (en) * 2005-04-13 2006-10-26 The Procter & Gamble Company Structured multi-phased personal care composition comprising branched anionic surfactants
US7820609B2 (en) * 2005-04-13 2010-10-26 The Procter & Gamble Company Mild, structured, multi-phase personal cleansing compositions comprising density modifiers
US20120015009A9 (en) * 2005-06-07 2012-01-19 The Procter & Gamble Company Multi-phased personal care composition comprising a blooming perfume composition
CN101326106A (en) * 2005-12-08 2008-12-17 宝洁公司 A container comprising an in-mold label positioned proximate to a surface topography
US20070141001A1 (en) 2005-12-15 2007-06-21 The Procter & Gamble Company Non-migrating colorants in multi-phase personal cleansing compositions
US20070167338A1 (en) * 2006-01-09 2007-07-19 Mchugh Colin M Multiphase personal care compositions comprising beads
US8104616B2 (en) 2006-02-11 2012-01-31 The Procter & Gamble Company Clamshell package for holding and displaying consumer products
US8153144B2 (en) 2006-02-28 2012-04-10 The Proctor & Gamble Company Stable multiphase composition comprising alkylamphoacetate
US20070297996A1 (en) * 2006-06-22 2007-12-27 The Procter & Gamble Company Multi-phase composition comprising a sunscreen
US8469621B2 (en) * 2007-02-27 2013-06-25 The Procter & Gamble Company Personal care product having a solid personal care composition within a structure maintaining dispenser
US8105996B2 (en) * 2007-03-30 2012-01-31 The Procter & Gamble Company Multiphase personal care composition comprising a structuring
US8158566B2 (en) * 2007-03-30 2012-04-17 The Procter & Gamble Company Multiphase personal care composition comprising a structuring system that comprises an associative polymer, a low HLB emulsifier and an electrolyte
US20090028808A1 (en) * 2007-07-27 2009-01-29 The Procter & Gamble Company Personal care article for sequentially dispensing compositions with variable concentrations of partitioned benefit or suspended benefit agents
US20090028809A1 (en) * 2007-07-27 2009-01-29 Jonathan Robert Cetti Personal care article for sequentially dispensing compositions with variable concentrations of hydrophobic benefit materials
US20090324520A1 (en) * 2007-07-27 2009-12-31 Jonathan Robert Cetti Personal-care article for sequentially dispensing compositions with variable concentrations of partitioned benefit or suspended benefit agents
US20100190675A1 (en) * 2009-01-28 2010-07-29 Jonathan Robert Cetti Personal Care Article For Sequentially Dispensing Compositions With Variable Concentrations Of Hydrophobic Benefit Materials
CN107106474B (en) 2014-11-10 2021-06-01 宝洁公司 Personal care composition with two benefit phases
US11207248B2 (en) 2014-11-10 2021-12-28 The Procter And Gamble Company Personal care compositions with two benefit phases
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
EP3697375B1 (en) 2017-10-20 2021-12-01 The Procter & Gamble Company Aerosol foam skin cleanser
EP3697374B1 (en) 2017-10-20 2022-02-16 The Procter & Gamble Company Aerosol foam skin cleanser
US10960570B2 (en) 2018-03-01 2021-03-30 Hexion Inc. Additives for lignocellulosic composites
CN113015904A (en) 2018-11-29 2021-06-22 宝洁公司 Method for screening personal care products

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254105A (en) * 1975-10-11 1981-03-03 The Lion Dentifrice Co., Ltd. Multiple emulsion having a form of water/oil/water phase and process for preparation thereof, and multiple emulsion type cosmetics
WO1996002230A1 (en) * 1994-07-19 1996-02-01 Unilever Plc Detergent composition
WO1996037420A1 (en) * 1995-05-26 1996-11-28 Unilever Plc Treatment regime for skin
WO1997017938A1 (en) * 1995-11-13 1997-05-22 Unilever Plc Three-phase emulsion cosmetic composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839156A (en) * 1987-04-17 1989-06-13 Colgate-Palmolive Company Stable hydrogen peroxide dental gel
KR930011983A (en) * 1991-12-16 1993-07-20 원본미기재 Self-tanner cosmetic composition
US5929019A (en) * 1997-01-30 1999-07-27 Lever Brothers Company, Division Of Conopco, Inc. Cleansing composition with separately dispensed cleansing base and benefit base wherein benefit base also comprises surfactant
FR2769224B1 (en) * 1997-10-03 2000-01-28 Oreal STABLE W / O / W EMULSION AND ITS USE AS A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION
EP0916334A1 (en) * 1997-11-07 1999-05-19 Unilever Plc Detergent composition
US6177092B1 (en) * 1998-11-10 2001-01-23 Color Access, Inc. Self-foaming cleansing systems

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254105A (en) * 1975-10-11 1981-03-03 The Lion Dentifrice Co., Ltd. Multiple emulsion having a form of water/oil/water phase and process for preparation thereof, and multiple emulsion type cosmetics
WO1996002230A1 (en) * 1994-07-19 1996-02-01 Unilever Plc Detergent composition
WO1996037420A1 (en) * 1995-05-26 1996-11-28 Unilever Plc Treatment regime for skin
WO1997017938A1 (en) * 1995-11-13 1997-05-22 Unilever Plc Three-phase emulsion cosmetic composition

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6758411B2 (en) 2002-08-09 2004-07-06 S. C. Johnson & Son, Inc. Dual bottle for even dispensing of two flowable compositions
WO2004026276A1 (en) * 2002-09-20 2004-04-01 The Procter & Gamble Company Striped liquid personal cleansing compositions containing a cleansing phase and a separate benefit phase
WO2004094582A1 (en) * 2003-04-16 2004-11-04 Reckitt Benckiser (Uk) Limited Multiple emulsion cleaning compositions
US7776812B2 (en) 2003-04-16 2010-08-17 Reckitt Benckiser (Uk) Limited Multiple emulsion hard surface cleaning compositions
US8840871B2 (en) 2008-07-28 2014-09-23 The Procter & Gamble Company Multiphase personal care composition with enhanced deposition

Also Published As

Publication number Publication date
JP2003512408A (en) 2003-04-02
AU1021701A (en) 2001-05-08
CA2385718A1 (en) 2001-05-03
US6268322B1 (en) 2001-07-31

Similar Documents

Publication Publication Date Title
US6268322B1 (en) Dual chamber cleansing system, comprising multiple emulsion
EP1282681B1 (en) Dual chamber cleansing system
AU615277B2 (en) Skin cleansing and moisturizing composition and method of using and preparing same
JP2911402B2 (en) Effervescent oil-in-water emulsion comprising nonionic surfactant, oil phase and gelling agent and its use in topical application
EP0755243B1 (en) Detergent composition
AU717000B2 (en) Skin toning formulation
US5929019A (en) Cleansing composition with separately dispensed cleansing base and benefit base wherein benefit base also comprises surfactant
US4970220A (en) Skin conditioning composition
AU615279B2 (en) Skin moisturizing composition and method of preparing same
US5871758A (en) Dual phase cosmetic composition
MXPA06012192A (en) Personal care compositions that deposit hydrophilic benefit agents.
NZ203953A (en) Skin or hair conditioning compositions
ES2226951T3 (en) HAIR MOLDING COMPOSITIONS OF THE HAIR.
JP2002502807A (en) Foaming skin cleansing products
WO1997025973A1 (en) Compositions for treating hair or skin
JPH10513179A (en) Roll-on antiperspirant composition
AU666641B2 (en) Gel type compositions having improved oil control
WO1996002224A1 (en) Detergent composition
JP2008100937A (en) O/w type finely emulsified preparation for external use and method for producing the same
JP2006188461A (en) Cosmetic
WO2001028502A1 (en) Stable multiple emulsion composition
JP4348030B2 (en) Transparent detergent composition
JP2020066623A (en) Cleansing composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2385718

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 532728

Kind code of ref document: A

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase